| 标题 |
Cost-effectiveness analysis of disitamab vedotin plus toripalimab versus chemotherapy as treatment for HER2-expressing advanced urothelial cancer in China |
| 网址 | |
| DOI |
10.1136/bmjopen-2026-117595
doi
|
| 其它 |
期刊:BMJ Open 作者:Yize Jia; Lin Zhu; Shuo Kang; Xiaohui Wang 出版日期:2026-08-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)